Ki-67 MIB1 Labelling Index and the Prognosis of Primary TaT1 Urothelial Cell Carcinoma of the Bladder

Journal of Clinical Pathology - United Kingdom
doi 10.1136/jcp.2004.022939
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Immunoexpression of Ki-67 in Determining Prognosis of Oral Cavity Squamous Cell Carcinoma

Padjadjaran Journal of Dentistry
2019English

Ki-67, P53, BCL-2 and Bax Expression in Urothelial Carcinomas of Urinary Bladder

Turk Patoloji Dergisi
Forensic MedicinePathology
2010English

Semi‑automated Evaluation of Ki‑67 Index in Invasive Ductal Carcinoma of the Breast

Oncology Letters
Cancer ResearchOncology
2013English

Cadmium in Urothelial Carcinoma of the Bladder

Polish Journal of Pathology
MedicineForensic MedicinePathology
2014English

Urothelial Carcinoma of the Bladder and the Rise of Immunotherapy

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2017English

What Is the Prognostic Significance of Ki-67 Positivity in Oral Squamous Cell Carcinoma?

Journal of Cancer
Oncology
2016English

CD10 Expression in Urothelial Carcinoma of the Bladder

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2009English

Standardized Ki‐67 Proliferation Index Assessment in Early Stage Laryngeal Squamous Cell Carcinoma in Relation to Local Control and Survival After Primary Radiotherapy

Clinical Otolaryngology
MedicineOtorhinolaryngology
2019English

Urothelial Carcinoma of the Bladder, Lipid Cell Variant: A Case Report and Literature Review

Journal of Nippon Medical School
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy